SB-258719 | SB-258719 : Reverse agonist of 5-HT7 receptor
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (0 reviews)
In Vivo
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
HTR7
  • Ki:31.6 nM
  • EC50:20 nM
Reverse agonist
up to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
SB-258719 displays > 100-fold selectivity over a range of other receptors (5-HT1A, 5-HT1B, 5-HT1D, 5 ...

Potency
Cellular
In Vitro

HTR7

Mode of Action: Reverse agonist

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm970519e

Chemical Information

Molecular Formula C18H30N2O2S
SMILEs Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1
InChI InChI=1S/C18H30N2O2S/c1-15-8-11-20(12-9-15)13-10-17(3)19(4)23(21,22)18-7-5-6-16(2)14-18/h5-7,14-15,17H,8-13H2,1-4H3/t17-/m1/s1
Molecular weight 338.20 Da
AlogP 3.1260200000000022
HBond acceptors 4
HBond donors --
Atoms 53

References

Publications

Cross References

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 30 Oct 2023 )
Cellular Use Rating
Radioligand displacement data looks promising, but receptor selectivity in cells was not confirmed.
(on 14 Oct 2025 )
Cellular Use Rating
This is the only commercially available 5HT7 antagonist, which excuses the rather modest amount of data available for it. Care should be taken regarding the potential effects on the off-targets with pKi...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria